Interestingly, an increase in ERα but a decrease in ERβ expression has been observed in human thyroid cancer cells (83, 84), which suggests that, as for breast cancer, an imbalance in the expression of the two isoforms may favor human thyroid cancer progression (76, 81). The gene discussed is ESR1; the disease is thyroid gland carcinoma.